Loading…
The natural elimination rate of procalcitonin in patients with normal and impaired renal function
Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half...
Saved in:
Published in: | Intensive care medicine 2000-03, Vol.26 (S2), p.S212-S216 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3 |
---|---|
cites | |
container_end_page | S216 |
container_issue | S2 |
container_start_page | S212 |
container_title | Intensive care medicine |
container_volume | 26 |
creator | Meisner, M. Schmidt, J. Hüttner, H. Tschaikowsky, K. |
description | Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance < 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT] |
doi_str_mv | 10.1007/s001340051146 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_992880200</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2629295361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3</originalsourceid><addsrcrecordid>eNpVkM1LxDAQxYMouK4evQfv1clXmz3K4hcseFnPJUkTNkub1CRF_O_NohdhYJiZNz8eD6FbAvcEoHvIAIRxAEEIb8_QinBGG0KZPEcrYJw2vOX0El3lfKzKrhVkhdT-YHFQZUlqxHb0k6-DjwEnVSyODs8pGjUaX2LwAdea692GkvGXLwccYprqpwoD9tOsfLIDTjbUlVuCOZGu0YVTY7Y3f32NPp6f9tvXZvf-8rZ93DWGbHhpnLDCUMOkBKnBSXB2EK3hRFtGneK6I602TmrNJQfaESNa3ZJBaMWt45at0d0vtzr-XGwu_TEuqTrJ_WZDK5YCVFHzKzIp5pys6-fkJ5W-ewL9KcT-X4jsB5VjZcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>992880200</pqid></control><display><type>article</type><title>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</title><source>Springer Nature</source><creator>Meisner, M. ; Schmidt, J. ; Hüttner, H. ; Tschaikowsky, K.</creator><creatorcontrib>Meisner, M. ; Schmidt, J. ; Hüttner, H. ; Tschaikowsky, K.</creatorcontrib><description>Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance < 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s001340051146</identifier><language>eng</language><publisher>Heidelberg: Springer Nature B.V</publisher><subject>Creatinine ; Dopamine ; Gender ; Inflammation ; Intensive care ; Molecular weight ; Patients ; Plasma ; Proteins ; Renal replacement therapy ; Sepsis ; Urine</subject><ispartof>Intensive care medicine, 2000-03, Vol.26 (S2), p.S212-S216</ispartof><rights>Springer-Verlag Berlin Heidelberg 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Meisner, M.</creatorcontrib><creatorcontrib>Schmidt, J.</creatorcontrib><creatorcontrib>Hüttner, H.</creatorcontrib><creatorcontrib>Tschaikowsky, K.</creatorcontrib><title>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</title><title>Intensive care medicine</title><description>Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance < 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]</description><subject>Creatinine</subject><subject>Dopamine</subject><subject>Gender</subject><subject>Inflammation</subject><subject>Intensive care</subject><subject>Molecular weight</subject><subject>Patients</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Renal replacement therapy</subject><subject>Sepsis</subject><subject>Urine</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LxDAQxYMouK4evQfv1clXmz3K4hcseFnPJUkTNkub1CRF_O_NohdhYJiZNz8eD6FbAvcEoHvIAIRxAEEIb8_QinBGG0KZPEcrYJw2vOX0El3lfKzKrhVkhdT-YHFQZUlqxHb0k6-DjwEnVSyODs8pGjUaX2LwAdea692GkvGXLwccYprqpwoD9tOsfLIDTjbUlVuCOZGu0YVTY7Y3f32NPp6f9tvXZvf-8rZ93DWGbHhpnLDCUMOkBKnBSXB2EK3hRFtGneK6I602TmrNJQfaESNa3ZJBaMWt45at0d0vtzr-XGwu_TEuqTrJ_WZDK5YCVFHzKzIp5pys6-fkJ5W-ewL9KcT-X4jsB5VjZcA</recordid><startdate>20000301</startdate><enddate>20000301</enddate><creator>Meisner, M.</creator><creator>Schmidt, J.</creator><creator>Hüttner, H.</creator><creator>Tschaikowsky, K.</creator><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20000301</creationdate><title>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</title><author>Meisner, M. ; Schmidt, J. ; Hüttner, H. ; Tschaikowsky, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Creatinine</topic><topic>Dopamine</topic><topic>Gender</topic><topic>Inflammation</topic><topic>Intensive care</topic><topic>Molecular weight</topic><topic>Patients</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Renal replacement therapy</topic><topic>Sepsis</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meisner, M.</creatorcontrib><creatorcontrib>Schmidt, J.</creatorcontrib><creatorcontrib>Hüttner, H.</creatorcontrib><creatorcontrib>Tschaikowsky, K.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meisner, M.</au><au>Schmidt, J.</au><au>Hüttner, H.</au><au>Tschaikowsky, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The natural elimination rate of procalcitonin in patients with normal and impaired renal function</atitle><jtitle>Intensive care medicine</jtitle><date>2000-03-01</date><risdate>2000</risdate><volume>26</volume><issue>S2</issue><spage>S212</spage><epage>S216</epage><pages>S212-S216</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><abstract>Objective: Procalcitonin (PCT) plasma concentrations and its kinetic can be used as a diagnostic tool in critically ill patients and patients with sepsis. Since renal dysfunction is a frequent complication in these patients, and PCT is a protein with a low molecular weight, we have measured the half-life time of PCT after peak concentrations in patients with normal and impaired renal function. We also have analyzed the influence of patients age and gender on PCT elimination kinetic.¶Design: Prospective clinical study. Renal dysfunction was assessed by plasma creatinine. The half-life time of PCT was evaluated 24 and 48 h after acute induction of PCT, when the focus of PCT induction has rapidly been eliminated.¶Setting: Intensive care unit of our University hospital, a tertiary health care institution.¶Patients: 69 patients were included into the study.¶Interventions: None.¶Measurements and results: The half-life-time of PCT was not significantly altered during renal dysfunction (26.1-33.1 h, 25-50 percentiles, creatinine clearance < 30 ml/min) when compared with normal renal function (22.3-28.9 h). It neither correlated with creatinine clearance (p = 0.14), nor age (p = 0.99) or gender (p = 0.90, Pearson product-moment correlation).¶Conclusions: The data of the present study demonstrate that assement of PCT kinetic can also be used for diagnostic and prognostic reasons in patients with renal dysfunction. It may, however, exceed 24 h also in patients with normal renal function. As to the present knowledge, renal secretion does not contribute as a main pathway to PCT elimination.[PUBLICATION ABSTRACT]</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s001340051146</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0342-4642 |
ispartof | Intensive care medicine, 2000-03, Vol.26 (S2), p.S212-S216 |
issn | 0342-4642 1432-1238 |
language | eng |
recordid | cdi_proquest_journals_992880200 |
source | Springer Nature |
subjects | Creatinine Dopamine Gender Inflammation Intensive care Molecular weight Patients Plasma Proteins Renal replacement therapy Sepsis Urine |
title | The natural elimination rate of procalcitonin in patients with normal and impaired renal function |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20natural%20elimination%20rate%20of%20procalcitonin%20in%20patients%20with%20normal%20and%20impaired%20renal%20function&rft.jtitle=Intensive%20care%20medicine&rft.au=Meisner,%20M.&rft.date=2000-03-01&rft.volume=26&rft.issue=S2&rft.spage=S212&rft.epage=S216&rft.pages=S212-S216&rft.issn=0342-4642&rft.eissn=1432-1238&rft_id=info:doi/10.1007/s001340051146&rft_dat=%3Cproquest_cross%3E2629295361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c194t-f5e5c2c38808b0f80fed56c41be32fa4b716bcf8bb4840271c56b61d5ba4ef4e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=992880200&rft_id=info:pmid/&rfr_iscdi=true |